| Product Name | MF | CAS | Details |
|---|
| 1,5-Pentanediol | C5H12O2 | 111-29-5 | Details |
| 8-Oxaspiro[4.5]decan-1-one | C9H14O2 | 1380389-10-5 | Details |
| 4-Methyl-1-piperazinecarbothioamide | C6H13N3S | 33860-28-5 | Details |
| Indolin-7-ol hydrochloride | C8H10ClNO | 5027-74-7 | Details |
| Phenyl 4,6-O-benzylidene-a-D-thiomannopyranoside | C19H20O5S | 159407-19-9 | Details |
| 1-Deoxy-1-nitro-D-mannitol | C6H13NO7 | 14199-83-8 | Details |
| Methyl 4-formyl-1-naphthoate | C13H10O3 | 62855-40-7 | Details |
| 4-Benzyl-4-azaspiro[2.5]octan-7-ol | C14H19NO | 1909348-20-4 | Details |
| FAM53A Blocking Peptide | Details |
| Tuvirumab | 138660-97-6 | Details |
| 3-Methoxy-5-(trifluoromethyl)phenylacetic acid | C10H9F3O3 | 916421-04-0 | Details |
| 1-(Piperidin-4-yl)-1H,2H,3H-imidazo[4,5-b]pyridin-2-one dihydrochloride | C11H15ClN4O | 781649-84-1 | Details |
| 2-Amino-4-trifluoromethanesulfonylphenol | C7H6F3NO3S | 69245-43-8 | Details |
| GADD45 beta antibody | Details |
| Indole-3-acetyl-L-valine | C15H18N2O3 | 57105-42-7 | Details |
| 4-{[1,2,4]Triazolo[4,3-a]pyridin-3-yl}piperidine | C11H14N4 | 852627-78-2 | Details |
| 1,4,10-Trioxa-7,13-diazacyclopentadecane | C10H22N2O3 | 31249-95-3 | Details |
| 1-(5-Bromothiophen-2-yl)cyclobutane-1-carbonitrile | C9H8BrNS | 1514316-53-0 | Details |
| 1-Amino-indan-4-ol hydrochloride | C9H12ClNO | 133497-59-3 | Details |
| CCND1 antibody | Details |
| α-D-Galactose-1-phosphate | C6H13O9P | 2255-14-3 | Details |
| (R)-2-Methylmorpholine hydrochloride | C5H12ClNO | 168038-14-0 | Details |
| N,N-Dimethylisoquinoline-5-sulfonamide | C11H12N2O2S | 84468-22-4 | Details |
| Thieno[2,3-c]pyridine-4-sulfonyl chloride | C7H4ClNO2S2 | 1936220-93-7 | Details |
| 2-{1-[(tert-Butoxy)carbonyl]-5,5-dimethylpiperidin-2-yl}acetic acid | 2228242-58-6 | Details |
| Orange terpenes | 68647-72-3 | Details |
| AT1002 | C32H53N9O7S | 835872-35-0 | Details |
| 3-(4-Chlorophenyl)propanoyl chloride | C9H8Cl2O | 52085-96-8 | Details |
| 2,16-Kauranediol | C20H34O2 | 34302-37-9 | Details |
| 2-Methyl-4,5,6,7-tetrahydro-1,3-benzoxazol-4-one | C8H9NO2 | 201024-63-7 | Details |
| tert-Butyl 2-(hydroxymethyl)-4H,5H,6H,7H-[1,3]thiazolo[4,5-c]pyridine-5-carboxylate | C12H18N2O3S | 1269532-60-6 | Details |
| (2R,3S,4R)-4-C-((2R,3S)-N-Benzyl-3-tert.butylsilyloxy-2-azetidinyl)-3-O-tert.butyldimethylsilyl-2,3,4-trihydroxybutanoic acid methyl ester | Details |
| tert-Butyl N-[2-(1,2,3,4-tetrahydroquinolin-6-yl)ethyl]carbamate | C16H24N2O2 | 1267458-82-1 | Details |
| Carboxypeptidase inhibitor, from potato tuber | 56092-22-9 | Details |
| 3,5-Dimethylanisole | C9H12O | 874-63-5 | Details |
| 5-Methyl-1H-indazol-4-amine | C8H9N3 | 81115-60-8 | Details |
| 6-Methyl-2-(propan-2-yl)pyridine-3-carboxylic acid | C10H13NO2 | 1247348-67-9 | Details |
| PEX26 antibody | Details |
| 6-(methoxymethyl)pyridine-2-sulfinate lithium (I) | C7H10LiNO3S | 2225144-19-2 | Details |
| 5-Chloro-8-fluoro-4-{[(2-methylpyrimidin-4-yl)methyl]amino}quinoline-3-carbonitrile | C16H11ClFN5 | 1209580-54-0 | Details |
| TUBB3 protein (His tag) | Details |
| Oxythiamine chloride | C12H16ClN3O2S | 582-36-5 | Details |
| GTF2F1 antibody | Details |
| 2-(3,4-Dichlorophenyl)ethanol | C8H8Cl2O | 35364-79-5 | Details |
| 2-[3-(2-methylcyclopropyl)-1,2,4-oxadiazol-5-yl]acetate lithium (I) | C8H11LiN2O3 | 1955506-51-0 | Details |
| 2-[3-(Trifluoromethyl)-1H-pyrazol-1-yl]butanoic acid | C8H9F3N2O2 | 1006473-54-6 | Details |
| N-[2-(2-Oxo-1,3-oxazinan-3-yl)ethyl]acetamide | 1798634-78-2 | Details |
| rac-(1R,2R)-2-(Trifluoromethyl)cyclopropan-1-amine hydrochloride | C4H7ClF3N | 1287760-01-3 | Details |
| N-?(Dimethyloxido-?λ4-?sulfanylidene)?-carbamic chloride | C3H6ClNO2S | 1934421-30-3 | Details |
| 3-(Bromomethyl)-2-(trifluoromethyl)pyridine | C7H5BrF3N | 1227602-81-4 | Details |
| H-QIYAGIKVK-OH | Details |
| Vicriviroc malate | C32H44F3N5O7 | 541503-81-5 | Details |
| 3,4-Diethoxyphenylacetic acid | C12H16O4 | 38464-04-9 | Details |
| 5-Bromo-7-methyl-1H-indole-3-carbaldehyde | C10H8BrNO | 16076-86-1 | Details |
| Carbocysteine sulfoxide | C5H9NO5S | 5439-87-2 | Details |
| 4-{[1,2,4]Triazolo[4,3-a]pyridin-3-ylmethyl}aniline | C13H12N4 | 1016839-14-7 | Details |
| [1-(3-Methoxyphenyl)-1-methylethyl]amine hydrochloride | C10H15NO | 109138-28-5 | Details |
| 2-(2-chloro-4-formyl-6-methoxyphenoxy)acetic acid | C10H9ClO5 | 123022-07-1 | Details |
| (1S,3R)-3-[(2S)-2-Phenylpropanamido]cyclopentane-1-carboxylic acid | C15H19NO3 | 1824969-10-9 | Details |
| 1-(2,2,2-Trifluoroethoxy)propan-2-amine hydrochloride | C5H11ClF3NO | 1221723-04-1 | Details |
| 1,12-Dodecanedioic-2,2,11,11-d4 acid | C12H18D4O4 | 97543-02-7 | Details |
| 6-Amino-6-deoxy-1,2,3,4-di-o-isopropylidene-D-galactopyranoside | C12H21NO5 | 4711-01-7 | Details |
| CD235a antibody (FITC) | Details |
| 3-{[(4-Fluoro-2-methylphenyl)amino]methyl}benzonitrile | C15H13FN2 | 1021022-20-7 | Details |
| 3-Chloro-5-(1-pyrrolidinyl)pyridazine | C8H10ClN3 | 1033693-13-8 | Details |
| RGS9 Blocking Peptide | Details |
| DHX8 Blocking Peptide | Details |
| tert-Butyl N-[1-(cyclopentylcarbamoyl)-2-methylbutyl]carbamate | C16H30N2O3 | 1323197-65-4 | Details |
| 1-[4-Bromo-3-(trifluoromethyl)phenyl]cyclopropan-1-ol | C10H8BrF3O | 1539874-03-7 | Details |
| 4-(Morpholine-4-carbonyl)benzene-1-sulfonyl chloride | C11H12ClNO4S | 881005-36-3 | Details |
| 4-(4-Ethylpiperazin-1-yl)butan-1-ol | C10H22N2O | 110439-00-4 | Details |
| tert-Butyl 2-(3-oxocyclopentyl)pyrrolidine-1-carboxylate | 1947316-45-1 | Details |
| 3-(4-Acetyl-3,5-dimethyl-1H-pyrrol-2-yl)-3-oxopropanenitrile | C11H12N2O2 | 721417-24-9 | Details |
| [5-(4-Fluorophenyl)-1,3-oxazol-2-yl]methanol | C10H8FNO2 | 844818-52-6 | Details |
| 4-(4-tert-Butylphenoxy)-3-fluorobenzoic acid | C17H17FO3 | 1039970-54-1 | Details |
| 2-(3,4-Dimethoxy-benzylamino)-ethanol | C11H17NO3 | 24687-79-4 | Details |
| Methyl 4-oxo-4H,5H-thieno[3,2-c]pyridine-7-carboxylate | C9H7NO3S | 1360929-34-5 | Details |
| 4-[(2-Methylpyrimidin-4-yl)oxy]aniline | C11H11N3O | 1283979-71-4 | Details |
| 4-tert-Butyl 3-methyl thiomorpholine-3,4-dicarboxylate | C11H19NO4S | 343616-34-2 | Details |
| 2-Methanesulfonamido-3,3-dimethylbutanoic acid | C7H15NO4S | 1600940-76-8 | Details |
| 5-[(4-Bromo-1H-pyrazol-1-yl)methyl]-1,2-oxazole-3-carboxylic acid | C8H6BrN3O3 | 1007514-40-0 | Details |
| CMV IgM (IgG Low Avidity) Positive Human Plasma | Details |
| 4-(Oxetan-3-yloxy)pyridin-2-amine | C8H10N2O2 | 1600221-24-6 | Details |
| Methyl 2-(thiomorpholin-3-yl)acetate hydrochloride | C7H14ClNO2S | 1333933-79-1 | Details |
| ((3-chloro-5-(trifluoromethyl)(2-pyridyl))amino)iminomethane-1-thiol | C7H5ClF3N3S | Details |
| CCL19 antibody | Details |
| ZNF511 Blocking Peptide | Details |
| H-HSDAVFTDNYTR^-OH | Details |
| Rhodamine B isothiocyanate-dextran - Average MW 70,000 | Details |
| CRY2 antibody | Details |
| 1,4-Dimethyl-1H-pyrrole-3-carboxylic acid | C7H9NO2 | 351416-83-6 | Details |
| Peptide M | C81H141N21O31 | 110652-62-5 | Details |
| 5-[(2-Fluorophenyl)methyl]-1,3,4-oxadiazole-2-thiol | C9H7FN2OS | 1092307-62-4 | Details |
| Streptonigrin from streptomyces flocculus (racemic) | C25H22N4O8 | 1079893-79-0 | Details |
| Reactive blue 220 | 90341-71-2 | Details |
| N-Benzyl-5,5-dimethyloxolan-3-amine | C13H19NO | 1935643-50-7 | Details |
| 3-(1-methyl-1H-pyrazol-3-yl)prop-2-ynoate lithium | C7H7LiN2O2 | 2044835-02-9 | Details |
| 3'-O-Methylguanosine 5'-triphosphate lithium | Details |
| Synaptotagmin antibody (Thr202) | Details |
| N-Benzyl-2-chloro-N-ethylpropanamide | C12H16ClNO | 731011-91-9 | Details |
| Product Total： Product Page： | ||||
| 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 | ||||